Synthesis 2011(17): 2822-2832  
DOI: 10.1055/s-0030-1261034
PAPER
© Georg Thieme Verlag Stuttgart ˙ New York

Parallel Synthesis of 1-Substituted 5-(5-Oxopyrrolidin-3-yl)-1H-pyrazole-4-carboxamides

Peter Perdiha, Jernej Baškovča, Georg Dahmannb, Uroš Grošelja, Drago Kočara, Ana Novaka, Branko Stanovnika, Jurij Svete*a
a Faculty of Chemistry and Chemical Technology, University of Ljubljana, Aškerčeva 5, P.O. Box 537, 1000 Ljubljana, Slovenia
Fax: +386(1)2419220; e-Mail: Jurij.svete@fkkt.uni-lj.si;
b Boehringer Ingelheim Pharma GmbH & Co. KG, Medicinal Chemistry, 88397 Biberach, Germany
Further Information

Publication History

Received 5 May 2011
Publication Date:
08 August 2011 (online)

Abstract

A parallel solution-phase synthesis of 5-(5-oxo-1-phenylpyrrolidin-3-yl)-1H-pyrazole-4-carboxamide derivatives as conformationally constrained pyrazole analogues of histamine starting from itaconic acid was developed. The synthetic method comprises a five-step preparation of 1-substituted 5-(5-oxo-1-phenylpyrrolidin-3-yl)-1H-pyrazole-4-carboxylic acids followed by parallel amidation with various primary and secondary amines to give a library of 24 histamine analogues in good overall yields and in very high purities. The method is general and substrate-independent. All the amidations proceed smoothly and no major difference in reactivity is observed with respect to the structures of the reactants.

    References

  • 1a Dolle RE. Solid-Phase Synthesis of Heterocyclic Systems (Heterocycles Containing One Heteroatom), In Handbook of Combinatorial Chemistry. Drugs, Catalysts, Materials   Vol. 2:  Nicolaou KC. Hanko R. Hartwig W. Wiley-VCH; Weinheim: 2002.  p.643 
  • 1b Pernerstorfer J. Molecular Design and Combinatorial Compound Libraries, In Handbook of Combinatorial Chemistry. Drugs, Catalysts, Materials   Vol. 2:  Nicolaou KC. Hanko R. Hartwig W. Wiley-VCH; Weinheim: 2002.  p.725 
  • 2a Dolle RE. Le Bourdonnec B. Morales GA. Moriarty KJ. Salvino JM. J. Comb. Chem.  2008,  10:  753 
  • 2b Dolle RE. Le Bourdonnec B. Goodman AJ. Morales GA. Thomas CJ. Zhang W. J. Comb. Chem.  2009,  11:  739 
  • 2c Dolle RE. Le Bourdonnec B. Worm K. Morales GA. Thomas CJ. Zhang W. J. Comb. Chem.  2010,  12:  765 ; and references cited therein
  • 3a Patrick GL. In An Introduction to Medicinal Chemistry   3rd ed.:  Oxford University Press; Oxford: 2005. 
  • 3b Kazuta Y. Hirano K. Natsume K. Yamada S. Kimura R. Matsumoto S.-i. Furuichi K. Matsuda A. Shuto S. J. Med. Chem.  2003,  46:  1980 
  • 3c Liebscher J. Patzel M. Synlett  1994,  471 
  • 3d Elsner J. Boeckler F. Davidson K. Sugden D. Gmeiner P. Bioorg. Med. Chem.  2006,  14:  1949 
  • 3e Nenajdenko VG. Zakurdaev EP. Gololobov AM. Balenkova ES. Russ. Chem. Bull.  2005,  54:  220 
  • 3f Marshall DR. Rodriguez G. Thomson DS. Nelson R. Capolina A. Bioorg. Med. Chem. Lett.  2007,  17:  315 
  • 4 Svete J. In (4R*,5R*)-4-Benzoylamino-5-phenyl-3-pyrazolidinone - A Useful Building Block in the Synthesis of Functionalized Pyrazoles   Horvat MA. Golob JH. Nova Science Publishers, Inc.; New York: 2008.  p.129 ; (open access item: the pdf is available at https://www.novapublishers.com/catalog/product_info.php?products_id=16416), and references cited therein
  • 5 Stanovnik B. Svete J. Chem. Rev.  2004,  104:  2433 ; and references cited therein
  • 6a Pezdirc L. Cerkovnik J. Pirc S. Stanovnik B. Svete J. Tetrahedron  2007,  63:  991 
  • 6b Pezdirc L. Bevk D. Grošelj U. Meden A. Stanovnik B. Svete J. J. Comb. Chem.  2007,  9:  717 
  • 7a Bienayme H. Tetrahedron Lett.  1998,  39:  4255 
  • 7b Lorthioir O. McKeown SC. Parr NJ. Washington M. Watson SP. Tetrahedron Lett.  2000,  41:  8609 
  • 7c Westman J. Lundin R. Stalberg J. Ostbye M. Franzen A. Hurynowicz A. Comb. Chem. High Throughput Screening  2002,  5:  565 
  • 7d Henkel B. Sax M. Dömling A. Tetrahedron Lett.  2003,  44:  3679 
  • 7e Westman J. Lundin R. Synthesis  2003,  1025 
  • 7f Čebašek P. Wagger J. Bevk D. Jakše R. Svete J. Stanovnik B. J. Comb. Chem.  2004,  6:  356 
  • 7g Schwalbe T. Kadzimirsz D. Jas G. QSAR Comb. Sci.  2005,  24:  758 
  • 7h Čebašek P. Bevk D. Pirc S. Stanovnik B. Svete J. J. Comb. Chem.  2006,  8:  95 
  • 7i Malavašič Č. Brulc B. Čebašek P. Dahmann G. Heine N. Bevk D. Grošelj U. Meden A. Stanovnik B. Svete J. J. Comb. Chem.  2007,  9:  219 
  • 7j Baškovč B. Bevk D. Stanovnik B. Svete J. J. Comb. Chem.  2009,  11:  500 
  • 7k Pellegrino G. Leonetti F. Carotti A. Nicolotti O. Pisani L. Stefanachi A. Catto M. Tetrahedron Lett.  2010,  51:  1702 
  • 7l Hernandez S. Moreno I. SanMartin R. Gomez G. Herrero MT. Dominguez E. J. Org. Chem.  2010,  75:  434 
  • 8a Wyatt PG. Allen MJ. Chilcott J. Foster A. Livermore DG. Mordaunt JE. Scicinski J. Woollard PM. Bioorg. Med. Chem. Lett.  2002,  12:  1399 
  • 8b Manley PW. Breitenstein W. Brueggen J. Cowan-Jacob SW. Furet P. Mestan J. Meyer T. Bioorg. Med. Chem. Lett.  2004,  14:  5793 
  • 8c Gopalsamy A. Yang H. Ellingboe JW. Tsou H.-R. Zhang N. Honores E. Powell D. Miranda M. McGinnis JP. Rabindran SK. Bioorg. Med. Chem. Lett.  2005,  15:  1591 
  • 8d Kalesh KA. Liu K. Yao SQ. Org. Biomol. Chem.  2009,  7:  5129 
  • 8e Yang W. Ruan Z. Wang Y. Van Kirk K. Ma Z. Arey BJ. Cooper CB. Seethala R. Feyen JHM. Dickson JK. J. Med. Chem.  2009,  52:  1204 
  • 8f Yang FV. Shipe WD. Bunda JL. Nolt MB. Wisnoski DD. Zhao Z. Barrow JC. Ray WJ. Ma L. Wittmann M. Seager MA. Koeplinger KA. Hartman GD. Lindsley CW. Bioorg. Med. Chem. Lett.  2010,  20:  531 
  • 9 Kralj D. Grošelj U. Meden A. Dahmann G. Stanovnik B. Svete J. Tetrahedron  2007,  63:  11213 
  • 10 Kralj D. Novak A. Dahmann G. Grošelj U. Meden A. Svete J. J. Comb. Chem.  2008,  10:  664 
  • 11 Kralj D. Friedrich M. Grošelj U. Kiraly-Potpara S. Meden A. Wagger J. Dahmann G. Stanovnik B. Svete J. Tetrahedron  2009,  65:  7151 
  • 12 erovnik D. Grošelj U. Kralj D. Malavašič Č. Bezenšek J. Dahmann G. Stare K. Meden A. Stanovnik B. Svete J. Synthesis  2010,  3363 
  • 13 Janjić M. Grošelj U. Kralj D. Malavašič Č. Golobič A. Stare K. Dahmann G. Stanovnik B. Svete J. Helv. Chim. Acta  2011,  94:  in press; DOI: 10.1002/hlca.201100055 
  • 14 Paytash PL. Sparrow E. Gathe JC. J. Am. Chem. Soc.  1950,  72:  1415 
  • 15a Montalbetti CAGN. Falque V. Tetrahedron  2005,  61:  10827 
  • 15b Tonolio C. Formaggio F. Kaptein B. Broxterman QB. Synlett  2006,  1295 
  • 15c Bode JW. Curr. Opin. Drug Discovery Dev.  2006,  9:  765 
  • 15d Valeur E. Bradley M. Chem. Soc. Rev.  2009,  38:  606 
  • 15e Joullié MM. Lassen KM. ARKIVOC  2010,  (viii):  189 
  • 15f Shen B. Makley DM. Johnston JN. Nature  2010,  465:  1027 
16

The filtrates were always transferred back to the reaction tubes and evaporated together with the remainder of the reaction mixtures. However, subsequent triturations with other solvents did not produce another portion of the corresponding product.